Medical Technology and Devices (MTD; www.mtdglobal.com ) is pleased to announce the successful closing of the acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses, a strategic acquisition initially announced at the end of March. This acquisition marks a major step forward in MTD’s mission to provide superior diabetes and obesity care solutions on…

Dear partner in care of patients with diabetes – We’ve come to learn that there is a significant supply disruption with another leading brand of traditional and safety pen needles. Sudden supply outages for products that deliver life-saving drugs are cause for concern due to the potential impact on adherence to therapy. Supply disruptions also…